HIVAging
Meeting category
Date(s)
30 Sep 2020 - 2 Oct 2020
Meeting type
Virtual Meeting
Organizer
Platinum Level Support
Sponsor logos
ViiW

International Workshop on HIV & Aging 2020

Related Enduring Materials

Enduring Materials

Day 1 - Wednesday, 30 September 2020

-
Mentoring Talk
Judith Currier, MD, MSC
University of California, Los Angeles (UCLA), United States
Session 1: What Are the Major Gaps in Pharmacology in Aging? -
Pharma Perspective
Andrew Clark
Andrew Clark, MD
ViiV Healthcare, Brentford, UK
Aging, Monitoring Drug Levels, Changing Dosing, Adherence; Long-acting Agents
Jose Castillo-Mancilla, MD
University of Colorado School of Medicine, United States
Abstract Session -
Abstract-driven Presentations
Daytime Sleep Behavior and Cognitive Performance in Middle-Older Aged HIV+ and HIV- Adults: A Cross-Sectional Study of 502, 505 Participants in UK Biobank
Peng Li, Brigham and Women's Hospital, USA
Medications With Neurocognitive Adverse Effects Are Associated With Falls Among Women With and Without HIV
Christina Psomas, European Hospital Marseille, France
Age at Diagnoses of Heart Failure in Veterans Living With HIV
Sebhat Erqou, Providence VA Medical Center, USA
Evaluation of Prescribing Issues in Older Adults Living With HIV
Vivian Chen, University Of California- San Francisco, USA
The Association Between Transportation Barriers and Health Status in Middle-Aged and Older Adults Living With HIV in the Deep South
Caitlin Pope, University of Kentucky, USA
Lightning Poster Presentations Session -
Lightning Poster Presentations
Geriatric Syndromes in an Urban Elderly Population in Cameroon: A Focus on Disability, Sarcopenia and Cognitive Impairment
Marie Josiane Ntsama Essomba, Faculty of Medicine and Biomedical Sciences, Cameroon
Pooled Analysis of 4 International Trials of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Adults Aged >65 or Older Demonstrating Safety and Efficacy: Week 48 Results
Ian Mcnicholl, Gilead Sciences, USA
Molecular Signatures of Aging and Flu Vaccine Response in Healthy and HIV Infected Individuals
Stefano Rinaldi, University of Miami, USA
Immunological Age Prediction in HIV-Infected, Art-Treated Individuals
Lesley De Armas, University of Miami, USA
Association of Polyfunctional CMV-Specific T Cells With Frailty in HIV-Infected and -Uninfected Men
Weiying Zhang, Johns Hopkins Bloomberg School of Public Health, USA
Establishing and Reviewing a New Clinical Service for Managing Frailty in People Living With HIV: A Perspective From the United Kingdom
Howell Jones, Mrc Unit for Lifelong Health and Ageing at UCL, UK
Functional Variation in the Haptoglobin Gene Affects Risk of Neurocognitive Impairment in People With HIV During Aging
William Bush, Case Western Reserve University, USA
History of Early Life Stress Strengthens the Link Between VACS Scores and Inflammation Among Older Adults With HIV
Heather Derry, Weill Cornell Medicine, USA
A Study of Neurocognitive Performance in Women Living With and Without HIV in South Africa
Kennedy Otwombe, Perinatal HIV Research Unit, South Africa
The Impact of COVID-19 on Health Seeking Behaviors Among Older Adults Living With HIV in the Coachella Valley, California
Annie Nguyen, University of Southern California, USA
Associations Between Frailty and Clinical Characteristics, Comorbidities, and Substance Use Among People Living With HIV
Stephanie Ruderman, University of Washington, USA
Informal "Lobby discussions" on Zoom

Day 2 - Thursday, 1 October 2020

-
Introduction Day 2
Russell Tracy
Russell Tracy, PhD
University of Vermont (UVM), Vermont
Session 2: Fat -
ART-associated Issues, Fat and Muscle Density, The Significance of ART-associated Weight Gain on Aging
Jordan Lake
Jordan Lake, MD, MSc
UTHealth, USA, Houston, TX, USA
Fatty Liver and Implications for Aging
Giada Sebastiani
Giada Sebastiani, MD
McGill University Health Centre, Montreal, Canada
Abstract-Driven Presentations Session -
Abstract-Driven Presentations
Acceleration of Multiple Measures of Aging-Related Epigenetics During HIV Seroconversion
Beth Jamieson, David Geffen School of Medicine at UCLA, USA
Categorizing Risk for Older Persons Living With HIV: A Latent Class Analysis of Comorbidities
Brianne Olivieri-Mui, The Marcus Institute for Aging Research, USA
Altered Macrophage Phenotype and Lipidome Abnormalities May Contribute to Cardiovascular Disease Risk in Aging People With HIV
Emily Bowman, The Ohio State University, USA
Association of Sex Hormone-Binding Globulin With Bone Mineral Density and Physical Function Among Adults With and Without HIV and HCV
Jenny Pena Dias, Johns Hopkins University, USA
Cell-Free Urine Mitochondrial DNA as a Marker of Aging-Related Phenotypes in Older People Living With HIV
Carrie Johnston, NYP-Weill Cornell Medical Center, USA
Vδ1+ and Vδ2+ Gamma Delta (γδ) T Cell Subsets Are Distinctly Linked With Markers of Chronic Inflammation and Intestinal Permeability With Aviremic HIV Infection
Riley Pihl, Boston University, USA
Industry-Sponsored Symposium
Session 3: Bone -
Chair
Jordan Lake
Jordan Lake, MD, MSc
UTHealth, USA, Houston, TX, USA
Should We Still Care About Bone, Screening, Treatment, TDF vs TAF
Michael Yin , MD
Columbia University Medical Center, USA
Falls and Fractures, Treatment, Prevention
Todd Brown, MD, PhD
Johns Hopkins University, United States
Poster Session -
Poster Presentations
Informal "Lobby discussions" on Zoom

Day 3 - Thursday, 2 October 2020

-
Introduction Day 3
Scott Letendre
Scott Letendre, MD
University of California San Diego, USA
Session 4: Neuro Session -
Effects of HIV and Aging on the Brain
Avindra Nath
Avindra Nath, MD
NIH, Bethesda, MD, USA
Oral Health With Aging/Periodontal Disease and Dementia
Angela Kamer
Angela Kamer, MD
NYU Medical School, New York, NY, USA
Session 5: Sensory diseases and aging -
Eye Disease and HIV
Douglas Jabs
Douglas Jabs, MBA, MD, MS
Johns Hopkins University, Baltimore, MD, USA
Neuropathy
Ronald Ellis, MD, PhD
University of California San Diego, United States
Session 6: HIV / Geri Clinic -
Introduction: What Didn't Work
Kristine Erlandson, MD, MS
University of Colorado Denver- Anschutz Medical Campus, United States
HIV Over-50-years Clinic in London
Marta Boffito, MD, PhD, FRCP, MBA
Chelsea and Westminster Hospital NHS Foundation Trust; Imperial College London; United Kingdom
Geriatric HIV Consultation Clinic at Zuckerberg San Francisco General Hospital
Meredith Greene, MD
Indiana University School of Medicine, United States
Integrating geriatric assessments into HIV care
Sarah Schmalzle
Sarah Schmalzle, MD
University of Maryland, Baltimore, MD, USA
Government Partnerships
Eugenia Siegler, MD
Weill Cornell Medicine, New York City, United States
Wrap-up Day 3 and closing remarks
Kristine Erlandson
Kristine Erlandson, MD
University of Colorado Denver- Anschutz Medical Campus, Colorado
Informal "Lobby discussions" on Zoom
Overview
Welcome

The 11th edition of the International Workshop on HIV & Aging was held as a virtual conference on 30 September - 2 October 2020. 

The integration of antiretroviral therapy (ART) into HIV care has dramatically extended the life expectancy of those living with HIV. The longer life expectancy of people with HIV infection is changing the demographics of the HIV epidemic and currently, more than half of the people living with HIV are aged 45 or older.  Recent estimates in Europe suggest that more than 70% of those with HIV will be over the age of 50 by 2030, with a greater burden of co-morbidities and associated treatments. In comparison to similar HIV-negative populations, HIV-positive persons, even when on effective ART, experience an excess of morbidity and mortality.  Persons on ART rarely die from complications of AIDS, but instead have an early onset of aging complications including neurocognitive decline, osteoporosis and fractures, impaired physical function, frailty, and falls. The high priority of understanding the interaction between age and HIV infection is illustrated by recent summary reports from the HIV and Aging Consensus Project in the Journal of the American Geriatrics Society and ongoing NIH Program Announcements in “Multidisciplinary Studies of HIV/AIDS and Aging”, in addition to strong voices in the community. 

The multidisciplinary nature of HIV and aging requires the joint expertise of many areas, including geriatrics, internal medicine, HIV, pharmacology, psychology, and numerous subspecialties. Thus, the International Workshop on HIV & Aging was initiated in 2009 as a unique and much-needed platform for scientific exchange on the increasingly recognized difficulties encountered in the clinical care and design of research studies to improve the care of persons aging with HIV.  The interactive and focused setting of the workshop allows for the presentation and discussion of the latest developments and strategies for the future of persons aging with HIV.  Additionallt, the intimate size and focused nature of the workshop stimulates interaction, and the relationships formed between participants have led to many productive collaborations lasting well beyond the workshop itself.

As in previous years, the 2020 edition gathered a cross-disciplinary team of experts, trainees, and community members who are involved in HIV and aging research and the provision of care to older persons living with HIV.  The ultimate goals of this workshop are to stimulate and guide research that will enable better treatment methods and strategies for older adults with HIV, to encourage young investigators, and to stimulate new partnerships between investigators in HIV and aging.

On behalf of the Organizing Committee,

General Information 

COVID-19 Update
In light of the COVID-19 pandemic, the Organizing Committee of the International Workshop on HIV & Aging reached the difficult decision to transform this year's event into a completely virtual workshop. In this way, the program was delivered safely and conveniently.

To deliver a highly educational, interactive, and enjoyable experience, it was decided to spread the program over three days, from 30 September to 2 October. Ample time was reserved for discussion and virtual networking opportunities. We offered delegates a special reduced fee to participate in this online program.

We are available to answer any questions or concerns that you may have about your participation at the International Workshop on HIV & Aging 2020. For more information, please contact Victoria Sarasola (victoria.sarasola@amededu.com).

To stay updated on developments in relation to the International Workshop on HIV & Aging, make sure you are signed up for our newsletter.
Accreditation
An application has been made to the UEMS EACCME® for the CME accreditation of this event.
Satellite Symposium
Preliminary Program
Thursday, 1 October 2020

Aging and Co-Morbidities (Merck)

- Aging is a Risk factor of Weight gain for PLWH over 50: Don't Add an Additional One

- Don't Forget Women Who Are NOT of Child-Bearing Potential (Menopause, Depresion, Metabolic Disorders)

Practical Information 

Certificate of Attendance
A certificate of attendance was sent to participants by e-mail after the workshop.
Language
The official language of the workshop was English.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.
Liability and Insurance
By registering for the workshop, participants agree that the organizers do not accept responsibility for medical, travel, or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs as well as audio and video recordings are not permitted at the official workshop sessions. Only the official medical writer, appointed by the organization, may make recordings. All presentations, will be posted on the workshop website (under Workshop Materials) as soon as possible after the workshop is finished, provided that the speaker has provided permission to do so.
Committees

The members of the Organizing Committee (OC) are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts. 

Organizing Committee
Scientific Committee

The members of Scientific Committee are hand-picked by the Organizing Committee (OC) and the conference secretariat based on their significant contributions and commitment to the field. They assist the OC by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

  • Beau Ances, MD, Washington University in St. Louis, United States
  • Bruce Brew, MD, St. Vincent's Hospital, Australia
  • Daniel Duprez, MD, University of Minnesota, United States
  • Meredith Greene, MD, University of California, San Francisco, United States
  • Steven Grinspoon, MD, Massachusetts General Hospital, United States
  • Marica Holstad, PhD, Emory University, Atlanta, Georgia, United States
  • Amy Justice, MD, PhD, Yale School of Public Health, United States
  • Jordan Lake, MD, MSc, UTHealth, United States
  • Alan Landay, PhD, Rush University Medical Center, United States
  • Michael Lederman, MD, Case Western Reserve University, United States
  • Avindra Nath, MD, National Institutes of Health, United States
  • Eugènia Negredo, MD, PhD, Universitat Autònoma de Barcelona, Spain
  • Molly Perkins, PhD, Emory University, Atlanta, Georgia, United States
  • Sean Rourke, PhD, University of Toronto, Canada
  • Victor Valcour, MD, University of California, San Francisco, United States
  • Cara Wilson, MD, University of Colorado, United States
Support
Platinum Level
Gold Level
Endorsers
Language